Welcome to our dedicated page for Evolv Technologies Hldngs SEC filings (Ticker: EVLVW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Evolv Technologies Hldngs's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Evolv Technologies Hldngs's regulatory disclosures and financial reporting.
Ellenbogen Michael reported acquisition or exercise transactions in this Form 4 filing.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen reported an award of 28,318 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the company’s Class A common stock and has no expiration date.
The 28,318 RSUs will vest in full on the earlier of June 18, 2027 or the day immediately before the company’s next annual meeting date. Following this grant, Ellenbogen holds 28,318 RSUs directly, reflecting a compensation-related equity award rather than an open-market share purchase.
Evolv Technologies Holdings director Michael Ellenbogen exercised stock options and sold shares on the same day. He exercised options to acquire 80,745 shares of Class A Common Stock at an exercise price of $0.24 per share, then sold 80,745 shares at a weighted average price of $6.21 per share. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan entered into on June 12, 2025. Following these transactions, he holds 2,083,961 shares of Class A Common Stock directly and 151,135 shares indirectly through the Family Horizon Trust, and retains 977,759 stock options.
EVLV submitted a Form 144 notice for proposed sales of Class A Common shares, reflecting RSU vesting dated 06/15/2026. The filing lists 242,242 shares connected to the vesting and records prior sales by Michael P. Ellenbogen of 80,745 shares on 04/15/2026 and 05/15/2026.
Evolv Technologies Holdings director Michael Ellenbogen reported an exercise-and-sell transaction in Class A Common Stock. He exercised stock options for 80,745 shares at $0.24 per share and sold 80,745 shares at a weighted average price of $5.63 per share under a pre-arranged Rule 10b5-1 trading plan entered into on June 12, 2025, with sale prices ranging from $5.53 to $5.77. Following these transactions, he directly owns 2,083,961 shares and indirectly holds 151,135 shares through the Family Horizon Trust.
Evolv Technologies Holdings is clarifying that some market data sites misreported its recent revenue figures and outlook. The company confirms Q1 2026 total revenue was $46.3 million, up from $32.0 million in Q1 2025, a 45% year-over-year increase.
Evolv also confirms it has raised its full-year 2026 total revenue guidance range to $175 million to $180 million. The update is meant to ensure investors are relying on the company’s own disclosures rather than incorrect third-party data.
Evolv Technologies Holdings reported strong first quarter 2026 results with revenue of $46.3 million, up 45% from $32.0 million a year earlier, driven by new customers and expanded deployments. Ending ARR reached $127.3 million, a 20% year-over-year increase, underscoring growth in recurring subscription-based business.
The company posted a net loss of $5.0 million, or $0.03 per share, compared with a $1.7 million loss, or $0.01 per share, in the prior-year quarter, but improved profitability on an adjusted basis. Adjusted EBITDA rose to $3.9 million from $2.1 million, delivering an 8.5% margin.
Management raised its 2026 total revenue outlook to a range of $175 million to $180 million, reflecting about 20% to 23% year-over-year growth, while reaffirming expectations for year-end ARR of $145 million to $150 million and positive full-year adjusted EBITDA with high single-digit margins.
Evolv Technologies Holdings, Inc. Chief Financial Officer George C. Kutsor reported routine equity compensation activity. He exercised restricted stock units to acquire 138,888 shares of Class A common stock, then sold 51,448 shares at a weighted average price of $7.27 per share.
According to the filing, the sale was made solely to cover withholding taxes tied to RSU vesting, rather than as a discretionary stock sale. After these transactions, he directly holds 87,440 shares of Class A common stock and 277,778 RSUs, which vest in three equal annual tranches, each RSU representing a right to receive one share.
Evolv Technologies Holdings, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on electing two Class II directors, approving an advisory say-on-pay resolution, and ratifying PricewaterhouseCoopers LLP as auditor. Holders of Class A common stock as of April 24, 2026 may vote online or by proxy.
The company highlights strong 2025 performance, with revenue of $145.9 million, 40% growth driven by nearly 250 new customers and over 8,000 active systems. Annual Recurring Revenue reached $120.5 million, while net loss narrowed to $33.1 million and Adjusted EBITDA turned positive at $11.1 million. Cash and marketable securities totaled $69.0 million.
The Board emphasizes enhanced governance, including an independent chair, fully independent key committees, refreshed charters, anti-hedging and clawback policies, and director and executive stock ownership guidelines. Executive pay is positioned as performance‑driven, relying heavily on at‑risk incentives, market-based stock units, and rigorous financial targets, and previously received 98% stockholder support in 2025’s say‑on‑pay vote.
Evolv Technologies Holdings, Inc. Schedule 13G/A shows a joint filing by multiple General Catalyst entities regarding Class A Common Stock (CUSIP 30049H102). The filing identifies the reporting persons and their Delaware organization structure and cites a Joint Filing Agreement governing a coordinated filing under Rule 13d-1(k). Item 5 states ownership of 5 percent or less of a class. Specific share counts and percentages refer readers to the cover sheets (Line 9/11) rather than the main text shown.
Evolv Technologies Holdings director Michael Ellenbogen exercised stock options and sold shares in a routine, pre-planned transaction. He exercised 80,745 stock options at an exercise price of $0.24 per share, receiving the same number of Class A Common shares.
On the same day, he sold 80,745 Class A Common shares at a weighted average price of $6.32 per share under a Rule 10b5-1 trading plan. After these transactions, he directly owned 2,083,961 Class A Common shares and indirectly held 151,135 shares through the Family Horizon Trust.